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Animal models, learning lessons to
prevent and treat neonatal chronic
lung disease
Alan H. Jobe*
Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA
Bronchopulmonary dysplasia (BPD) is a unique injury syndrome caused by prolonged
injury and repair imposed on an immature and developing lung. The decreased septation
and decreased microvascular development phenotype of BPD can be reproduced in
newborn rodents with increased chronic oxygen exposure and in premature primates and
sheep with oxygen and/or mechanical ventilation. The inflammation caused by oxidants,
inflammatory agonists, and/or stretch injury frommechanical ventilation seems to promote
the anatomic abnormalities. Multiple interventions targeted to specific inflammatory cells
or pathways or targeted to decreasing ventilation-mediated injury can substantially
prevent the anatomic changes associated with BPD in term rodents and in preterm
sheep or primate models. Most of the anti-inflammatory therapies with benefit in animal
models have not been tested clinically. None of the interventions that have been tested
clinically are as effective as anticipated from the animal models. These inconsistencies
in responses likely are explained by the antenatal differences in lung exposures of the
developing animals relative to very preterm humans. The animals generally have normal
lungs while the lungs of preterm infants are exposed variably to intrauterine inflammation,
growth abnormalities, antenatal corticosteroids, and poorly understood effects from the
causes of preterm delivery. The animal models have been essential for the definition of the
mediators that can cause a BPD phenotype. These models will be necessary to develop
and test future-targeted interventions to prevent and treat BPD.
Keywords: prematurity, lung injury, inflammation, oxidant injury
Introduction
My charge is to evaluate the contributions from animal models that have resulted in better care
to prevent and treat chronic lung disease in newborns, which I will refer to as bronchopulmonary
dysplasia (BPD). I will focus exclusively on the BPD associated with very preterm birth (1). This
review will move between observations in animal models and the clinical syndrome of BPD with a
skeptical eye toward how results frommodels have translated to clinical outcomes. The cynic might
say that there has been no progress in the care of infants with BPD based on a recent systematic
review of randomized controlled trials (RCT) for the prevention of BPD (2). Of 47 RCTs for drug
therapies, only eight showed benefits for five agents (vitamin A, caffeine, dexamethasone, inositol,
and clarithromycin) and none of the 47 trials were registered for an Investigational New Drug
for BPD. This depressing perspective is in part the result of the lack of trial data to document
the continuing improvements in respiratory support and general clinical care that have strikingly
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decreased mortality for preterm infants since 1967. For example,
the two major interventions of surfactant and antenatal corticos-
teroid treatments decrease the incidence and severity of respira-
tory disease syndrome (RDS) and decrease mortality after very
preterm birth (3, 4). The collateral damage of increased survival
is that more high infants are at risk of developing BPD. Antenatal
corticosteroids and surfactant change the population of infants at
risk for BPD but do not decrease the incidence of BPD. As the dis-
ease has evolved to primarily occur in the most immature infants,
the concepts about pathophysiology depend more on studies of
developing lungs in preterm and term animals. This review will
focus primarily on models of BPD in term newborn and preterm
animals. My perspective of the pathophysiology of BPD is that the
programs required for normal lung development from the saccu-
lar to the alveolarized lung are clashing with prolonged exposures
to lung injuries from oxygen toxicity, mechanical stretch, and
inflammation and simultaneously with repair programs to yield a
most complex and varied pathophysiology (Figure 1). Each of the
three elements in the equation – development, injury, and repair –
is crucial to anticipating how an animal model might contribute
to understanding the pathophysiology of BPD and to the testing
of treatment strategies.
An Historical Perspective on Animal
Models of BPD
Oxygen and BPD
Soon after the description of BPD as a progressive lung injury in
ventilated premature infants exposed to at least 150 h of 80–100%
oxygen (5), Northway’s group reported that newborn mice sur-
vived for weeks in 100% oxygen with only a small increase in
lung wet weights (6, 7). In contrast, adult mice died within sev-
eral days and had heavy and inflamed lungs. The histopathology
in the newborns demonstrated type II cell proliferation and a
hypertrophic bronchiolar epithelium. This increased survival of
FIGURE 1 | Overview of “big events” in pathophysiology of BPD. The
three major programs that are active during the course of BPD are lung
development, injury, and repair. The major injuries are from oxygen and
ventilation-associated inflammation. The time line for the fetus and infant
occurs over months to years, which contrasts to studies in term rodent
models.
newborns occurred despite low levels of the antioxidant enzymes
that ostensibly should put the newborn lung at increased risk of
injury (8). Nevertheless, the most frequently used animal model
for evaluating therapies for BPD is the newborn rodent – rats or
mice – exposed to various amounts of oxygen for periods of days
to weeks as reviewed by Hilgendorff et al. (9).
These rodent models are attractive as they are reproducible,
readily available, and relatively inexpensive. Oxidant injury of
the newborn rodent lung delays saccular septation to alveoli,
increases mesenchymal cellularity, causes a persistent inflamma-
tory response, blocks capillary formation in the distal lung, and
causes pulmonary hypertension (10). These changes are similar
to the abnormalities described for the lungs of infants who have
died of BPD after several months of life (11). Oxygen toxicity
models are deceptively simple and are assumed to capture the key
elements of the pathophysiology of BPD. However, multiple vari-
ables of relevance to BPD canmodulate oxygen toxicity responses.
As noted above, high concentrations of oxygen kill adult rodents
within about 3 days but newborns can survive for weeks in 100%
oxygen (6). This transition to oxygen sensitivity occurs after about
30 days of age in the rat (12). Calorie restriction of pregnant rats or
newborn rabbits increases the oxygen sensitivity of the lung (13).
In adult rats and mice, a variety of exposures prior to an exposure
to 100% oxygen can greatly decrease mortality from oxygen – the
phenomenon of preconditioning. For example, adult rats exposed
to 100% oxygen for 48 h and then returned to air for 24 h prior to
a second exposure to 100% oxygen survived for 7 days (14). A pre-
exposure of adult rats to endotoxin survive for>3 days in oxygen
(15). Fetal sheep exposed to antenatal corticosteroids or to intra-
amniotic endotoxin have large increases in antioxidant enzymes
in the fetal lungs (16, 17). Many infants at risk of BPD have
been exposed to intra-amniotic infection, corticosteroids, and
nutritional deficits. Further, hypoxia is a potent preconditioning
exposure (18). The assumption generally is that extremely low
birth weight (ELBW) infants are very sensitive to oxygen toxicity.
However, the animal model data suggest that ELBW infants may
have quite variable sensitivities to oxygen at different times during
their clinical course because of their antenatal and postnatal expo-
sures. There is no information about oxygen sensitivity in ELBW
infants or how that might be assessed (19).
Ventilation and BPD
In 1960s,mechanical ventilation of large preterm infantswithRDS
with primitive ventilators and no positive end expiratory pres-
sure (PEEP) resulted in mortality rates of about 70% worldwide.
In that context, Northway and colleagues (5) hypothesized that
the combination of very high and prolonged oxygen exposure,
together with mechanical ventilation, caused the new syndrome
of BPD. The initial animal models explored the oxygen exposure
component of the injury and no clinical progress was made with
ventilation strategies until Gregory and colleagues in 1971 (20)
described continuous positive airway pressure (CPAP) to open
the atelectatic and surfactant deficient lungs of infants with RDS
which improved oxygenation and survival. CPAP was quickly
designed into infant ventilators to provide PEEP. The respiratory
care of the larger infant with RDS was transformed within several
years without much in the way of clinical trials or animal-based
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research. However, smaller and more immature infants now sur-
vived with a new variant of BPD (11).
Animal models then became critical for understanding the
link between mechanical ventilation and injury of the preterm
lung. Robertson and colleagues developed techniques for short-
term ventilation of preterm rabbits, primarily to test physiological
responses to surfactant treatments (21). They described severe
bronchiolar epithelial disruption within minutes of ventilation
of surfactant deficient preterm rabbits (22). The epithelial injury
resulted in airspace flooding with intravascular proteins, which
could be prevented with surfactant treatment (23). Escobedo
et al. (24) and Coalson et al. (25) ventilated premature baboons
with oxygen and described chronic BPD-like lung changes as a
model to explore the pathogenesis of BPD. This group related
the progression of “diffuse alveolar damage” from the combined
exposures of oxygen and mechanical ventilation to similar studies
in adult baboonswith adult respiratory distress syndrome (ARDS)
(26). The exudative response to the injurywas delayed and blunted
in the preterm relative to the adult, a result consistent with less
injury from oxygen. However, airway injury was more severe in
the preterm lungs. The review of BPDbyO’Brodovich andMellins
(27) in 1985 identified oxygen as the primary instigator of BPD,
although mechanical ventilation was recognized as a contributor.
Concurrently, with extensive adult animal model research on
the mechanical causes of lung injury (28, 29), short-term stud-
ies with preterm sheep demonstrated that the preterm lung was
exquisitively sensitive to lung injury from volutrauma (30). With
the initiation of ventilation of the fluid-filled lung of the preterm
lamb with just six very large tidal volumes of 35–40ml/kg, the
preterm lung was injured such that there was no response to
surfactant treatment (31) (Figure 2). Tidal volumes of 20ml/kg
for 30min of ventilation resulted in better compliance and gas
FIGURE 2 | High tidal volumes inure the preterm lung. Six large tidal
volumes given by hand at delivery injure the preterm lamb lung and prevent a
response to surfactant given at 30min of age. Redrawn from data in Ref.
(31). B. An initial tidal volume of 20ml/kg results in a high compliance in
preterm lambs relative to a low tidal volume of 5ml/kg, but at 30min of age,
the surfactant response is lost with the high tidal volume. The low tidal
volume to 30min of age allows the lungs to respond to surfactant. Redrawn
from data in Ref. (32).
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exchange than tidal volumes of 5 or 10ml/kg, but the higher
tidal volume injured the lungs (32). This result is similar to the
outcomes of tidal volume ventilation of ARDS patients: a higher
tidal volume resulted in better gas exchange in the short-term but
more mortality from lung injury (33).
The association of both mechanical ventilation and oxygen
with BPD in infants and premature animal models is inevitable
as both the infants and the animals generally require both to
survive. Using short-term fetal mechanical ventilation with air
in sheep, O’Reilly et al. (34) reported injury and bronchiolar
remodeling over 7 days. Hillman et al. (35) of ventilated exterior-
ized fetal sheep for 15min with 100% nitrogen or 100% oxygen
and returned the animals to the uterus for 3 h. Expression of
response genes and cytokines demonstrated large injury responses
but no differences between the nitrogen- and oxygen-exposed
lungs.With chronic ventilation of preterm lambs for 3weeks using
oxygen concentrations<30%, Bland et al. (36) reported increased
and abnormally distributed elastin and reduced expression of
growth factors that regulate alveolarization. Innovative experi-
ments with ventilated newborn mice for 7 h with 40% oxygen
or room air disrupted elastin synthesis and increased apoptosis
(37). A subsequent study with 24 h air ventilations of newborn
mice demonstrated increased apoptosis and an inhibition of alve-
olarization and microvascular development, the key findings in
BPD (38). These effects were remarkable in that the ventilation
induced the BPD phenotype quickly and without a concurrent
oxygen exposure or inflammation. In contrast to newborn mice,
room airmay be “hyperoxic” for the very pretermhuman lung and
is thus an unavoidable exposure. Nevertheless, these experiments
with mice in the saccular phase of lung development are proof
of principle that mechanical ventilation alone can cause a BPD
phenotype.
Lung injury from mechanical ventilation has progressed from
considerations of pressure (barotrauma) to focused analyses of
tidal volumes (volutrauma), atelectotrauma (ventilation from low
lung volumes), and biotrauma (proinflammatory mediators), pri-
marily using adult animal models (39, 40). Strategies to decrease
ventilator-induced lung injury (VILI) are major components of
efforts to improve outcomes for patients with ARDS (39). VILI
was recently compared in adults, children, and with an analysis of
animal models (41). Newborn rodents have larger lung volumes
[functional residual capacity (FRC) and total lung capacity (TLC)]
than adult rodents, which seems to translate to less injury at a
given tidal volume in the newborn than for adult animals (42, 43).
However, the term newborn rodent is not a good model for the
preterm infant at risk of BPD. The preterm infant has a low FRC
and a low TLC compared with the term infant or the adult human
(30). Further, the surfactant-deficient preterm lung requires mean
airway pressures> 20 cmH2O to maximally recruit lung volume
(44). The preterm lung is easier to overstretch because the chest
wall is compliant and the lung collagen matrix is insufficient to
limit stretch of both the airways and the parenchyma (45). The
lung volume available between FRC and TLC for safe mechanical
ventilationmay be as low as 15ml/kg. Thus, with an unstable FRC
and a poorly defined TLC, VILI can easily occur with mechanical
ventilation. The animal models most relevant for understanding
how ventilation injury contributes to BPD are preterm sheep or
primates who can be ventilated for prolonged periods so that
injury progression can be evaluated.
Inflammation and BPD
A common theme since the early days of BPD research is the
association between inflammation and BPD. Airway aspirates
from infants with early lung injury that progresses to BPD contain
increased numbers of inflammatory cells and proinflammatory
cytokines (46, 47). As in adult animal models with high oxygen
exposures alone, newborn rodent lungs respond to injury with
recruitment and activation of inflammatory cells and increased
proinflammatory cytokines in alveolar washes (10). Similarly,
stretch-mediated injury causes a brisk proinflammatory response
in preterm sheep (35). Very preterm baboon lungs developing
BPD from oxygen and mechanical ventilation have greatly ele-
vated proinflammatory cytokines for the 4-week period of study
(48) (Figure 3). The preterm fetal sheep lung has a large inflam-
matory response to just 15min of stretch from ventilation with
nitrogen using high (15ml/kg) or to relatively normal tidal vol-
umes of 6ml/kg (49, 50). The inflammatory response is less with
the lower tidal volume, with antenatal corticosteroid treatment,
with surfactant treatment prior to ventilation, or with ventilation
with PEEP (51–53). However, even combinations of approaches
will not eliminate an inflammatory response with ventilation of
the preterm fetal lung. Further, the 15min lung stretch injury is
greatly amplified if the preterm fetus is subsequently delivered
and ventilated for brief periods. These experiments in baboons
FIGURE 3 | Cytokines are persistently elevated in airway samples from
ventilated preterm baboons. IL-6 and IL-8 were increased from day 1 to
week 4 in preterm baboons progressing to BPD. Data redrawn from Coalson
et al. (48).
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and sheep demonstrate that the preterm lung can generate rapid
and very prolonged inflammatory responses to care elements that
most ELBW infants need for survival.
However, the clinical environment is much more complex as
more than 50% of ELBW infants will have been exposed to infec-
tion/inflammation from chorioamnionitis prior to delivery (54).
An increased risk of BPD may be associated with fetal exposure
to histologic chorioamnionitis, although the increased risk has
been inconsistent in the multiple evaluations of the association
(55). Watterberg et al. (56) made the intriguing observation that
preterm infants exposed to histologic chorioamnionitis had a
decreased risk of RDS but an increased risk of BPD. The infants
exposed to chorioamnionitis had increased amounts of inflamma-
tory mediators and cells in airway aspirates collected shortly after
birth. Therefore, the lung inflammation proceeded the delivery
and subsequent exposures to oxygen and ventilation. The diffi-
culty with a consistent interpretation of the clinical data is that
chorioamnionitis is caused by organisms ranging from commen-
sals to pathogens, the fetal exposure is for various periods prior to
delivery, and the intensities of the exposures are variable (57).
Animal models have been effectively used to characterize the
ranges of fetal lung responses to inflammatory exposures. Bry
et al. (58) first reported that intra-amniotic injections of inter-
leukin 1 (IL-1)-induced lung maturation in preterm fetal rabbits
asmeasured by increasedmRNA for surfactant proteins, increased
surfactant lipids, and improved pressure–volume curves. Intra-
amniotic injections in fetal sheep of IL-1 or E. coli endotoxin
lipopolysaccharides (LPS), but not IL-6, IL-8, or TNF-α, induce
chorioamnionitis and early lung maturation as measured by large
increases in pressure–volume curves and lung mechanics and
gas exchange within 5 to 7d (59–61). The improvement in lung
performance is proceeded by increases in mRNA for the surfac-
tant proteins and then by increases in surfactant lipids (62). The
clinical phenotype consistent with these early maturational effects
would be a decrease in the severity of RDS, which should decrease
the risk of BPD.
The maturation response to fetal exposure to chorioamnionitis
induced by IL-1 or LPS is proceeded by modest inflammation
characterized by recruitment of activated granulocytes to the fetal
lung parenchyma and airspaces, high levels of proinflammatory
cytokine expression, increased apoptosis, and subsequent cell pro-
liferation (63). This injury response includes a transient inhibition
of alveolar septation and causes pulmonary vascular injury with
increased smooth muscle in vessel walls and decreased media-
tors of vascular development (64, 65). The fetal lung has more
functional maturation and more antioxidant enzymes but with
septation and microvascular injuries consistent with a mild BPD
phenotype. Despite prolonged exposure to intrauteral inflamma-
tion, infants have not been described as having BPD at birth. This
observation is consistent with the animal models, as repetitive
or continuous exposures for 28 days to intra-amniotic LPS do
not cause progression of the septation and microvascular injuries
(66). In fact, the preterm lung heals despite continued exposures
to proinflammatory agonists. The proinflammation is downregu-
lated soon after exposure to agonists, and the fetal lung “tolerizes”
in that subsequent inflammatorymediator exposures do not incite
inflammation in the fetal lung (67). LPS is the agonist most used
in animal models to evaluate effects on the fetal lung. LPS inhibits
structural development of the fetal mouse lung via TLR4 receptors
and NF-kB activation with suppression of FGF-10 (68, 69). Medi-
ators such as TGF-β1 and the SMADS are induced while others
such as connective tissue growth factor (CTGF) and caveolin-1
are suppressed, demonstrating multiple effects on LPS on the fetal
lung that may contribute to the changes of BPD (70, 71).
Multiple different organisms and polymicrobial infections have
been associated with histologic chorioamnionitis, but different
clinical presentations have not been associated with the types
of infection (57). In the fetal sheep or monkey, quite distinct
responses of fetal exposures to organisms and mediators can be
demonstrated. Intra-amniotic LPS or IL-1 causes limited but very
complex inflammatory responses that yield the phenotypes of
lung maturation, a mild BPD, and immune tolerance (67, 72).
Ureaplasma species are the most frequent organisms associated
with preterm labor and they may cause chronic and indolent
colonization (infection?) and have been associated with BPD (73).
Ureaplasma readily colonize the amniotic fluid of fetal sheep
and cause a generally mild but variable chorioamnionitis that
can persist for months (74). The fetal lung has a very mod-
est inflammatory response with low-grade cytokine expression
and a small increase in granulocytes (75). However, the induced
lung maturation and microvascular changes are reminiscent of
LPS effects (76, 77). In contrast, intra-amniotic Candida albicans
causes a modest chorioamnionitis but a severe consolidating and
necrotizing pneumonia with a progressive lethal fetal inflamma-
tion within about 3 days (78). These varied responses in animal
models provide the insight that chorioamnionitis may initiate
BPD by decreased septation and microvascular injury in fetal life
but may also protect from BPD by inducing lung maturation and
increasing antioxidant enzymes. As recently reviewed by Wright
and Kirpalani (79), attempts to target inflammation have not
translated to therapies for BPD.
Animal Models to Evaluate Therapies
for BPD
Overview
The major elements of BPD that have been targeted for thera-
pies are the arrest of alveolarization, the blunted microvascular
development, and the inflammation that is generally considered
a common path to the septation and vascular abnormalities. The
concept that inflammation was a common mediator for the pro-
gression of BPD resulted from the observations that inflammation
accompanied oxygen toxicity and ventilation-mediated injury in
newborn and adult animals and that overexpression of most any
proinflammatory cytokine in newborn mice lungs resulted in
inflammation and septation abnormalities (11). Early examples
of a BPD phenotype were overexpression of TGF-α, IL-11, and
IL-6 (80–82). More recently, overexpression of IL-1β or bioactive
TGF-β1 in airway epithelial cells in newborn mice were proposed
as models of BPD (83, 84). The experimental strategy to assess a
therapeutic benefit has generally been to cause a BPD-like injury
with oxygen exposure of newborn rodent lungs and to assess
agonists or antagonist effects on inflammation and changes in
septation and/or microvascular development. Primate and sheep
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models of combined ventilation and oxygen exposure have been
used to better replicate clinical reality and to test interventions
such as high-frequency ventilation (HFV) and inhaled nitric oxide
(iNO). I will assume that newborn rat and mouse models of
oxygen exposure are equivalent and I will not address stem cell
therapies. In general, the reports focus on individual mechanisms
and pathways, but many of the interventions may have pleotropic
(and presently unknown) effects.
BPD Therapy by Blocking Inflammatory Cells
If BPD is caused by chronic inflammation in the developing
lung, then blocking the major inflammation factories – the
granulocytes and macrophages should be effective. Auten et al.
(85) demonstrated that antibodies to the cytokine – induced
neutrophil chemoattractant-1 (CINC-1) effectively blocked neu-
trophil recruitment to the lungs and alveolar washes of 95%
oxygen-exposed newborn rats and alveolar architecture was pre-
served. This observation was extended to demonstrate that block-
ing the signaling of CINC-1 through its receptor CXC chemokine
receptor-2 with a small molecular weight antagonist completely
blocked neutrophil influx into the lungs of 60% oxygen-exposed
newborn rats (86). Surprisingly, the 60% oxygen exposure,
together with blocked neutrophil influx, enhanced lung growth
and septation. Treatment of newborn rats with 60% oxygen and
IL-1 receptor antagonist blocked neutrophil recruitment to the
lungs and improved alveolar septation with less of an effect on
the pulmonary vascular injury (87). Neutrophil recruitment to the
lungs of fetal sheep exposed to LPS can be effectively blocked by
either an anti-CD-18 antibody or by intra-amniotic IL-1 receptor
antagonist (88, 89). Either strategy to decrease inflammatory cell
recruitment to the fetal lungs prevents both the injury and the
lung maturation responses. Strategies to interfere with neutrophil
recruitment to prevent BPD have not been tried in infants at risk.
Such strategies have not been effective for ARDS and infants have
depressed immune responses that would be further compromised
by inhibition of granulocyte function.
The normal developing lung contains fewmature macrophages
until after birth when an increase in GMCSF in the lungs activates
the transcription factor PU-1 in immature monocytes to differen-
tiate to mature monocytes (90). However, macrophages become
prominent in airway samples of infants with BPD. Monocytes in
the lungs of fetal sheep exposed to a 15min volutrauma injury
mature within 24 h to macrophages as do fetal lung monocytes
exposed to intra-amniotic LPS (90, 91). Jankov et al. (92) used
gadolinium chloride to block macrophage influx into the lungs of
newborn rats exposed to 60% oxygen. The treatment decreased
macrophages and prevented smooth muscle hypertrophy in pul-
monary vessels and prevented pulmonary hypertension but not
the septation defect – a partial response at best. As with inhibitors
of granulocyte recruitment, macrophage depletion may put the
preterm at risk of infection.
Targeting overall lung cell metabolism has not been exploited
for a possible therapy for BPD. In newborn mice exposed to
75% oxygen, decreased septation correlated with decreased mito-
chondrial oxidative phosphorylation (93). Thus, a general cellular
bioenergetics failure maybe a fundamental mechanism contribut-
ing to BPD. Inflammasome-mediated cytokine injury has not
been explored in the developing lung. Mechanical ventilation of
adult mice activated inflammasomes with IL-18 release, an effect
that was blocked with an anti-IL-18 antibody with reduced lung
injury (94). These reports may be relevant to future BPD research.
Antioxidants to Prevent BPD
Increased oxygen exposure is considered a major cause of BPD,
and oxygen is the agonist for the newborn rodent models of
BPD. Lung antioxidant enzymes are decreased with preterm birth
(8), so that antioxidant treatments are logical. Clinically, N-
acetylcysteine and recombinant superoxide dismutase did not
decrease BPD (95, 96). Vitamin A, which may have antioxidant
effects, did modestly decrease BPD (97). Consistent with the clin-
ical result, Vitamin A improved septation and alveolar capillary
growth in chronically ventilated preterm lambs (98). Vitamin A
also modulated elastin metabolism and the expression of vascular
growth factors as mechanisms distinct from antioxidant effects.
In preterm ventilated baboons given 100% oxygen for 10 days,
a small molecular weight catalytic antioxidant improved lung
anatomy relative to untreated animals (99). Peroxynitrites are
products of oxidant exposure, and a catalyst that decomposes
peroxynitrite decreased both the alveolarization and the vascular
injuries resulting from exposure of newborn rats to 60% oxygen
(100, 101). The animal model research with antioxidants for BPD
is not extensive and might be a productive avenue toward a
therapy.
Nitric Oxided to Prevent BPD
The animalmodel literature on the benefits of iNO for the preterm
lung is large and positive. Lambs exposed to mechanical ven-
tilation have decreased neutrophil accumulation and edema if
exposed to iNO (102). iNO also attenuates pulmonary hyperten-
sion and improves lung growth in newborn rats exposed to hyper-
oxia (103), as does the related compound ethyl nitrate (104). iNO
also corrects the lung structural abnormalities and pulmonary
hypertension from a bleomycin-induced lung injury in neonatal
rats that resembles BPD (105). iNO can improve the lung struc-
tural abnormalities caused by blockade of the vascular endothe-
lial growth factor (VEGF) receptor, suggesting iNO effects on
growth factor signaling (106). These beneficial effects translated
to chronically ventilated large animal models in preterm lambs
and baboons. Bland et al. (107) found that iNO protected ven-
tilated lambs from alveolar simplification and increased airway
resistance. iNO treatment of preterm ventilated baboons over
14 days improved lung function, improved septation, preserva-
tion of lung growth, and normalization of extracellular matrix
deposition (108). As a treatment strategy to mimic NO signaling,
Ladha et al. (109) treated newborn 95% oxygen-exposed rats
with sildenafil to increase cGMP and improved alveolar growth
with less pulmonary hypertension. Another approach used by
McCurnin et al. (110) was to give estradiol to increase NO syn-
thases, a treatment that improved lung function of preterm ven-
tilated baboons over 14 days, but without clear effects on lung
structure or elastin deposition. Despite this extensive literature
in both newborn rodents and chronically ventilated sheep and
baboons that identify multiple beneficial effects of iNO, multiple
clinical trials show no consistent benefit of iNO for the prevention
of BPD in preterm infants (111), a most disappointing result.
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Growth Factors in the Pathogenesis of BPD
Lung growth from the saccular to alveolar stages of development
is regulated by multiple growth factors that may be dysregulated
during the course of BPD. In newborn rats, inhibition of VEGF
decreases lung septation and microvascular development in par-
allel (112), a phenotype similar to the oxygen-exposed newborn
rodent. Therefore, Kunig et al. (113) exposed newborn rats to 75%
oxygen for 14 days and then treated the animals with intramuscu-
lar injections of rhVEGF and demonstrated improved recovery of
vascular growth and alveolarization relative to controls. A similar
result was reported for prevention of the initial oxygen injury
in newborn rats (114). The vascular and alveolar development
that was inhibited by 95% oxygen did not occur with postnatal
adenovirus-mediated VEGF therapy. Optimal treatment included
both VEGF and angiopoietin-1 gene transfers to decrease the
vascular leakage caused by the increased VEGF expression. Such
a complex treatment would be impractical in humans, but the
prevention of injury and repair responses of the oxygen-injured
rodent lung are proof of principal that VEGF dysregulation likely
contributes to clinical BPD.
Other growth factors also have therapeutic benefits in animal
models of BPD. Keratinocyte growth factor (KGF or FGF7) can
protect newborn rats from death from pulmonary hypertension
but not for the decreased septation in >95% oxygen over the
first 2 weeks of life (115). Franco-Montoya et al. (116) noted
that intraperitoneal KGF prevented neutrophil recruitment to
the airspaces of >95% oxygen-exposed newborn rats with less
decrease in DNA or cell proliferation, but the structural changes
in the newborn lungs were not changed by KGF treatment. Thus,
any treatment benefits of KGF in the rodent model were partial
at best.
In contrast, hepatocyte growth factor (HGF) hadmore remark-
able effects on newborn rodent lungs exposed to 90% oxygen.
Intraperitoneal HGF partially corrected increased airway resis-
tance and hyper-responsiveness, improved the alveolar simplifi-
cation, and increased the microvasculature (117). Platelet-derived
growth factor can have long-term effects on septation if its sig-
naling is disrupted with a receptor antagonist even briefly (118).
Therapy with PDGF has not been reported in BPDmodels. Subra-
maniam and colleagues (119) report that bombesin-like peptides
predict the severity of BPD in ventilated preterm baboons, and an
antibody to these peptides improved the septation. Clearly, multi-
ple growth factors act in time and space to regulate lung devel-
opment. Although animal models support growth factor–based
treatments for BPD, caution is warranted as such therapies may
have adverse effects on other developing systems.
Other Treatments for BPD in Animal Models
Glucocorticoid treatments have been used for the prevention of
BPD (early treatments) and to treat the progression of BPD (120).
Although there are concerns about the pleotropic developmental
effects, dexamethasone can decrease the incidence of BPD and
mortality. The presumed mechanism of action is as a potent anti-
inflammatory. Cyclooxygenase-2 (Cox-2) is upregulated in the
60%oxygen exposure rodentmodel of BPD and in lungswith BPD
(121). Therefore, Masood and colleagues (122) used a selective
Cox-2 inhibitor to suppress prostaglandin production during oxy-
gen exposure of newborn rats with remarkable results. The Cox-2
inhibitor prevented recruitment of neutrophils and macrophages
and blocked the inhibition of alveolar septation and the increase
in tissue fraction caused by oxygen. Choo-Wing et al. (121) used
transgenic technology to overexpress interferon-γ and small inter-
fering RNA to inhibit the endoplasmic reticulum stress pathway
in hyperoxia-exposed newborn mice. A Cox-2 inhibitor or the
siRNA prevented the arrest of alveolarization caused by INFα
and hyperoxia. These results suggest inhibition of Cox should
be an effective therapy for BPD, but indomethacin or ibuprofen
treatments of infants to decrease intraventricular hemorrhage or
to close the patent ductus arteriosus are not associated with a
decrease in BPD (123). However, specific Cox-2 inhibitors have
not been directly tested to prevent BPD.
TGF-β1 is an important mediator of both stimulation and
inhibition of lung cell development and airway branching (124).
Airspace fluids from infants with BPD contain increased amounts
of TGF-β1 and antenatal intra-amniotic LPS greatly induce TGF-
β1 in the lungs of fetal lambs (70). Nakanishi et al. (125) demon-
strated the alveolar and vascular abnormalities caused by 95%
oxygen in newborn mice can be partially prevented with a TGF-β
neutralizing antibody.
Focal elastin bundles identify the sites of septation, and inhibi-
tion of elastin formation or abnormal distributions of increased
amounts of elastin in saccular/alveolar walls inhibit septation.
Ventilated and oxygen-exposed preterm lambs have inhibited
alveolarization. Lung growth factors (VEGF, PDGF-A) and their
receptors were decreased at 3weeks (36). Elastin-related gene
expression increased and discrete septation initiation sites were
lost with prolonged ventilation of the preterm lamb. Remark-
ably, these effects on septation sites to uncouple the synthesis
and assembly of elastin can occur within 24 h of mechanical
ventilation in newborn mice (37). Using the ventilated newborn
mouse model, Hilgendorff et al. (126) then showed that intratra-
cheal treatment with the elastase inhibitor elafin prevented elastin
degradation, TGF-β activation, apoptosis, and decreased the sep-
tation abnormality. This result was reproduced using newborn
mice that overexpressed elafin (126). These experiments demon-
strate a therapeutic strategy that simply decreases the elastin
degradation that accompanies mechanical ventilation.
Other pathways activated by oxygen or bleomycin exposure of
newborn rodents demonstrate both the complexity of the oxygen
injury, but also how targeting single pathways can prevent much
of the injury. Rho-kinase is a ubiquitously expressed protein that
regulates numerous cell functions and proliferation. It is upreg-
ulated by bleomycin in the newborn rat, and inhibition of Rho-
kinase decreases the BPD-like changes caused by bleomycin (127).
B-catenin is another multifunctional signaling protein that is crit-
ical for normal lung development and remodeling and aberrant
β-catenin signaling has been associated with BPD. In the 90%
oxygen-exposed newborn rat model, an inhibitor of β-catenin
mitigated the septation defect and pulmonary hypertension (128).
A recent observation is that an extract from a Chinese traditional
herb Astragalus membranaceus has anti-inflammatory effects and
protects newborn rats from oxygen injury (129). Finally, infants
with BPD often have hypercarbia. Although hypercarbia can
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have deleterious effects on the lung (130), in the newborn rat
hypercapnea blunted the influx of macrophages, and the resulting
pulmonary hypertension caused by bleomycin (131). With use of
TNF-α inhibitor, the benefits of hypercapnea were explained by
fewer macrophages secreting TNF-α.
Ventilation Strategies to Decrease Lung
Injury
High-Frequency Oscillatory Ventilation
Mechanical ventilation of the premature infant is a major contrib-
utor to lung injury that progresses to BPD. A strategy to minimize
injury that was initially tested in preterm animals was high-
frequency oscillatory ventilation (HFOV). Preterm baboons sup-
ported byHFOVrequired less supplemental oxygen andhad fewer
air leaks than animals supported with conventional mechanical
ventilation (CMV) (132). All HFV animals survived for 11 days
while 5 of 11 animals on CMV died within 48 h. In 6 h exper-
iments, Jackson and colleagues (133) reported that premature
Macaca nemestrina ventilated with HFV had better expanded
lungs with less alveolar debris and better gas exchange. Other
measures of lung injury were not different. A subsequent report
with this primate model demonstrated that HFV when combined
with surfactant treatment caused less injury than HFV or surfac-
tant treatments alone (134). Yoder et al. (135) used very preterm
baboons at 125 days gestational age (GA) who were exposed to
antenatal steroids and treated with surfactant at birth to compare
HFV with CV using tidal volumes of 4–6ml/kg for 1–2 months.
Prolonged HFV resulted in better lung mechanics, a lower oxy-
gen requirement, and lower cytokine levels in airway samples at
selected timesV when combined to 1month of age. At autopsy,
the HFV animals had better inflated lungs, but both groups had
pathologic changes of BPD. Overall the animal studies support
substantial benefits of HFV relative to CMV. Unfortunately, meta-
analyses of 3,260 randomized infants found no net benefit of
HFV for decreasing BPD (136). An individual patient analysis of
nine trials to evaluate HFV relative to CMC also showed no BPD
benefit for HFV (137). However, a recent report demonstrated
better pulmonary function tests at 11–14 years of age for infants
randomized to HFC relative to CMV (138). Overall, the animal
testing was not predictive of clinical benefit.
Tidal Volumes and Continuous Positive Airway
Pressure
The preterm lung can be easily injured with high tidal volumes
as demonstrated by the effects of high tidal volumes following
birth (31, 32). Animalmodels were used to evaluate chronic effects
of tidal volumes and non-invasive ventilation strategies. Preterm
surfactant-treated lambs were randomized to 20 breaths/min with
15ml/kg tidal volumes or 60 breaths/min with 6ml/kg tidal vol-
umes for 3–4weeks by Albertine et al. (139). Both ventilation
groups had abnormal alveolarization relative to age matched non-
ventilated controls. The high tidal volume animals had more
impaired alveolarization and more elastin than the low tidal
volume animals. Studies of similarly ventilated lambs showed
decreased pulmonary microvasculature, interstitial edema and
increased pulmonary arteriolar smoothmuscle and elastin in both
groups of animals (140).
Animal models also were used to test the hypothesis that non-
invasive respiratory support would injure the preterm lung less
than CMV. 125 days GA baboons were treated with surfactant and
stabilized with CMV for 24 h before extubation to nasal CPAP for
4weeks (141). As compared to fetal controls, the CPAP animals
had enlarged thin walled air spaces, but with minimal injury
compared to animals supported with CMV. A second study with
preterm baboons evaluated an early 24 h extubation to CPAP or
a delayed 5 days extubation to CPAP (142). The delayed CPAP
group had worse oxygenation and more inflammation and higher
proinflammatory cytokine levels in the airway samples than did
the early CPAP group, but morphometry for alveolarization was
similar between groups. Preterm lambs ventilated using either
non-invasive high-frequency nasal ventilation or CMV with tidal
volumes of 5–7ml/kg were evaluated at 3 days for the effects of the
ventilation style on mesenchymal cell apoptosis and proliferation
(143). The non-invasive ventilation achieved more thinning of
the mesenchyme with more apoptosis and less proliferation that
supported alveolarization better than the CMV group. As with the
HFO studies, these non-invasive ventilation approaches decreased
a variety of indicators of lung injury better than CMV. However,
comparisons of CPAP strategies with intubation, surfactant treat-
ment, andCMVhadonlymarginal benefits to prevent BPD in four
trials in very low birth weight infants (144).
Preconditioning for BPD-Like Responses of
Newborn Lungs
The animal models and treatments described so far have used
a single lung injury – oxygen, bleomycin, or ventilation – to
induce BPD-like changes in developing lungs. Clinical medicine
is much more complex because of the multiple associations with
preterm delivery. There is a large literature about how an antenatal
exposure can modulate a postnatal exposure (18). A representa-
tive example is the report by Tang et al. (145) that demonstrates
that fetal exposure of mice to intra-amniotic LPS causes a BPD
phenotype in the newborn mice. Postnatal exposure to >95%
oxygen increases the BPD-like abnormalities. However, postnatal
exposure to 65% oxygen has the opposite effect of accelerated
lung growth and attenuated pulmonary hypertension. A second
example is the competing effects of intracervical E. coli and
betamethasone on postnatal hyperoxic exposures in rats (146).
The hyperoxic responses were increased by the antenatal inflam-
mation but attenuated by the combination of inflammation and
betamethasone. A post-delivery exposure such as hyperoxia also
can aggravate lung injuries later in life. Newborn mice exposed to
100% oxygen for 4 days and allowed to recover in room air were
much more sensitive to bleomycin-induced fibrosis or influenza
virus as adults (147, 148). The important message is that one
exposure that may cause a BPD phenotype may be substantially
modified by a previous or subsequent exposure. These complex
exposures can only be evaluated in animal models.
Summary
The animal models of BPD that use premature sheep, primates, or
newborn rodents have injury responses that are similar to what is
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known about the pathology of BPD. A cautionary note is that the
pathology is only available for infants who have died of end stage
BPD, with few exceptions. The range of abnormalities may be far
greater for themajority of infantswho survive BPD to remodel and
grow their lungs. The interventions in animal models to decrease
oxidant injury, inflammation, and volutrauma each show rather
striking benefits for the major pathologies of decreased septa-
tion and microvascular development. Given the list of positive
strategies enumerated in this review, effective treatments should
be either in use or in late stages of development. But they are not.
My explanation is that the animals are studied as normal
fetuses or newborns, and virtually all preterm infants are abnormal
because of the abnormalities associated with very preterm deliv-
ery, primarily placental dysfunction, fetal exposure to infection,
and fetal growth restriction (149). Further, >80% of the infants
have been exposed to antenatal corticosteroids (1). Precondition-
ing events likely change each infant’s responses to oxygen, ventila-
tion, and inflammation. The clinical responses also are likely to be
modulated by the genetic variability in humans that is greatlymin-
imized in the animal models. For example, clinical interventions
that have been extensively trialed such as antenatal corticosteroids
and surfactant treatments required several hundred humans to be
randomized to show clinically relevant effects such as decreased
mortality (3, 4). Experiments with sheep or primates with group
numbers of four to eight can show highly significant differences in
physiological outcomes such as lung compliances or oxygenation.
Effects of antenatal steroids or surfactant on BPD are minimal in
human trials because of decreased mortality with more high-risk
infants surviving.
However, the animal models of BPD have shaped our under-
standing of the disease. Care strategies have improved which has
allowed the survival of smaller and more fragile infants. Less
aggressive approaches to ventilation, better nutrition, and better
control of postnatal infection are hard to document, but in my
view are of substantial benefit to preterm infants. Finally, a major
deficiency is the clinical definition of BPD that is based on a
therapy – supplemental oxygen. The diagnosis does not directly
inform the clinician about how the lungs are working or what
the abnormalities may be. It may be most difficult to evaluate a
therapy based on animal models if there is not more precision in
knowing what components of BPD the therapy should improve.
Therapies targeting specific pathways that are effective in animal
models are most difficult to translate into a safe and effective ther-
apy in preterm infants because of constraints on clinical research
in this population. However, animal models will have a critical
role in refining our understanding of the pathophysiology of lung
injury and repair in the future. Research strategies should include
more complex models with multiple and sequential fetal and/or
newborn lung injuries. A focus on repair mechanisms may be
more informative than studies of acute injury mechanisms. The
identification of biomarkers that can be used to identify primary
injury or repair pathways may help in the testing of treatments
in infants, as surrogate indicators are preferable to long-term
outcomes for studies in infants.
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